450Pimpact of baseline, trend, and normalization of carcinoembryonic antigen on survival in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with first-line epidermal growth factor receptor tyrosine kinase inhibitors
Chen, Y.-M.; Lai, C.-H.; Lin, M.-C.
Annals of Oncology 26(Suppl 9): ix 138.1-ix 138
2015
ISSN/ISBN: 0923-7534
DOI: 10.1093/annonc/mdv532.34
Accession: 067408879
PDF emailed within 0-6 h: $19.90
Related References
Chen, Y.-M.; Lai, C.-H.; Chang, H.-C.; Chao, T.-Y.; Tseng, C.-C.; Fang, W.-F.; Wang, C.-C.; Chung, Y.-H.; Huang, K.-T.; Chen, H.-C.; Chang, Y.-C.; Lin, M.-C. 2015: Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Medicine 94(50): E2239Chen, Y.-M.; Lai, C.-H.; Chang, H.-C.; Chao, T.-Y.; Tseng, C.-C.; Fang, W.-F.; Wang, C.-C.; Chung, Y.-H.; Wang, Y.-H.; Su, M.-C.; Huang, K.-T.; Chen, H.-C.; Chang, Y.-C.; Lin, M.-C. 2015: Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Plos one 10(8): E0136252
Chen, Y.-M.; Lai, C.-H.; Chang, H.-C.; Chao, T.-Y.; Tseng, C.-C.; Fang, W.-F.; Wang, C.-C.; Chung, Y.-H.; Wang, Y.-H.; Su, M.-C.; Liu, S.-F.; Huang, K.-T.; Chen, H.-C.; Chang, Y.-C.; Lin, M.-C. 2016: Antacid use and de Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Plos one 11(2): E0149722
Sun, S.; Yu, H.; Wang, H.; Zhao, X.; Zhao, X.; Wu, X.; Qiao, J.; Chang, J.; Wang, J. 2017: Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors Oncotargets and Therapy 10: 1955-1967
Chang, H.-C.; Chen, Y.-M.; Tseng, C.-C.; Huang, K.-T.; Wang, C.-C.; Chen, Y.-C.; Lai, C.-H.; Fang, W.-F.; Kao, H.-C.; Lin, M.-C. 2017: Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 39(3): 1010428317695939
Gao, W.; He, J.; Jin, S.D.; Xu, J.; Yu, T.F.; Wang, W.; Zhu, Q.; Dai, H.; Wu, H.; Liu, Y.Q.; Shu, Y.Q.; Guo, R.H. 2019: Association of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment and Egfr Exon 19 Deletion with Frequency of the T790M Mutation in Non-Small Cell Lung Cancer Patients After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors OncoTargets and Therapy Volume 12: 9495-9504
Gao, W.; He, J.; Jin, S-Dai.; Xu, J.; Yu, T-Fu.; Wang, W.; Zhu, Q.; Dai, H.; Wu, H.; Liu, Y-Qian.; Shu, Y-Qian.; Guo, R-Hua. 2019: Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Oncotargets and Therapy 12: 9495-9504
Jamal-Hanjani, M.; Spicer, J. 2012: Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(4): 938-944
Bouchez, C.ém.; Pluvy, J.; Soussi, G.; Nguenang, M.; Brosseau, S.; Tourne, M.; Collin, M.ég.; Théou-Anton, N.; Guyard, A.; Ammar, J.; Khalil, A.; Zalcman, G.ér.; Gounant, V.ér. 2020: Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors Bmc Cancer 20(1): 1186
Tan, C.-S.; Cho, B.-C.; Soo, R.A. 2016: Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer Lung Cancer 93: 59-68
Jänne, P.A.; Johnson, B.E. 2006: Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(14 Part 2): 4416s-4420s
Chen, Y.-M.; Lai, C.-H.; Rau, K.-M.; Huang, C.-H.; Chang, H.-C.; Chao, T.-Y.; Tseng, C.-C.; Fang, W.-F.; Chung, Y.-H.; Wang, Y.-H.; Su, M.-C.; Huang, K.-T.; Liu, S.-F.; Chen, H.-C.; Chang, Y.-C.; Chang, Y.-P.; Wang, C.-C.; Lin, M.-C. 2016: Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors Bmc Cancer 16(1): 868
Yin, Q.; Xun, X.; Yang, G.; Cui, H.; Liu, H. 2021: Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Adjuvant Setting for Patients with Resected Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: a Meta-Analysis with 11 Trials Oncology Research and Treatment 44(6): 344-353
Cui, S.; Ni, Y.; Zhao, Y.; Li, Z.; Xiong, L.; Liu, J.; Liang, X.; Jiang, L. 2019: Epidermal growth factor receptor-targeted immunomagnetic liposomes for circulating tumor cell enumeration in non-small cell lung cancer treated with epidermal growth factor receptor-tyrosine kinase inhibitors Lung Cancer 132: 45-53
Morgillo, F.; Hong, W.K.; Lee, H. 2016: Insulin-like growth factor-1 receptor/epidermal growth factor receptor (EGFR) heterodimerization and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer Journal of Clinical Oncology 24(18_Suppl): 13032-13032